KeyBanc downgraded BioMed Realty (NYSE: BMR) from Buy to Hold.

Analyst Jordan Sadler said, "We see a relatively more ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE